These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4798342)

  • 1. Pattern of the activator inhibitor in carcinoma and renal diseases.
    Hedner U; Nilsson IM
    Scand J Haematol; 1973; 11(5):398-404. PubMed ID: 4798342
    [No Abstract]   [Full Text] [Related]  

  • 2. On fibrinolytic split products in serum and urine in uraemia.
    Larsson SO; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1971; 5(3):234-42. PubMed ID: 5569348
    [No Abstract]   [Full Text] [Related]  

  • 3. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls.
    Carlsson S; Astedt B
    Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751
    [No Abstract]   [Full Text] [Related]  

  • 4. On coagulation and fibrinolysis in renal failure.
    Larsson SO
    Scand J Haematol Suppl; 1971; 15():1-59. PubMed ID: 5284430
    [No Abstract]   [Full Text] [Related]  

  • 5. Previously undescribed fibrinolysis inhibitor in human blood.
    Siegel-Ralston A; Astrup T
    Nat New Biol; 1971 Dec; 234(49):180-1. PubMed ID: 4257614
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen degradation products in serum from patients with cancer.
    Carlsson S
    Acta Chir Scand; 1973; 139(6):499-502. PubMed ID: 4753096
    [No Abstract]   [Full Text] [Related]  

  • 7. The significance of serum creatinine and the blood urea-serum creatinine ratio in azotaemia.
    Kahn S; Sagel J; Eales L; Rabkin R
    S Afr Med J; 1972 Nov; 46(47):1828-32. PubMed ID: 4539756
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T; Ichikawa T
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin breakdown products and fibrinolysis in renal disease.
    Wardle EN; Taylor G
    J Clin Pathol; 1968 Mar; 21(2):140-6. PubMed ID: 5697045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The possible prognostic usefulness of assessing serum proteins and cholesterol in malignancy.
    Chao FC; Efron B; Wolf P
    Cancer; 1975 Apr; 35(4):1223-9. PubMed ID: 1167805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation, clot lysis, and thrombosis. I. Acid-labile inhibitor of fibrinolysis in rats fed thrombogenic diets.
    Sisson JA; Lee KT; Jadick PF; Thomas WA
    Exp Mol Pathol; 1968 Apr; 8(2):159-70. PubMed ID: 4231027
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunochemical heterogeneity of calcitonin in renal failure.
    Lee JC; Parthemore JG; Deftos LJ
    J Clin Endocrinol Metab; 1977 Sep; 45(3):528-33. PubMed ID: 903401
    [No Abstract]   [Full Text] [Related]  

  • 13. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitors of the fibrinolytic enzyme system in renal disease.
    Bennett NB; Ogston D
    Clin Sci; 1970 Nov; 39(5):549-57. PubMed ID: 5493532
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the fibrinolytic activity in human semen studied by gel filtration.
    Hisazumi H
    Invest Urol; 1970 Mar; 7(5):410-21. PubMed ID: 5461871
    [No Abstract]   [Full Text] [Related]  

  • 16. On coagulation and fibrinolysis in uremic patients on maintenance haemodialysis.
    Larsson SO
    Acta Med Scand; 1971 Jun; 189(6):453-62. PubMed ID: 5113861
    [No Abstract]   [Full Text] [Related]  

  • 17. Gastrin levels and gastric acid secretion in anephric patients and in patients with chronic and acute renal failure.
    Falcao HA; Wesdorp RI; Fischer JE
    J Surg Res; 1975 Feb; 18(2):107-11. PubMed ID: 1094191
    [No Abstract]   [Full Text] [Related]  

  • 18. Applications and outcome of hemodialysis in cats: a review of 29 cases.
    Langston CE; Cowgill LD; Spano JA
    J Vet Intern Med; 1997; 11(6):348-55. PubMed ID: 9470160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
    Abiko Y; Iwamoto M
    Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
    [No Abstract]   [Full Text] [Related]  

  • 20. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.